Friday 6 November 2026 Export VRTX’s income statement to Excel — free account

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $12.0 billion, up 8.90% from fiscal 2024.

Revenue: +11.9%
EPS: −39.2%
Free cash flow: −52.1%

Quarter to September 2026, against a year earlier

547.43 4.93 +0.91%

Follow VRTX

Alert me

Market cap: $137.5B
P/E: 34.6×
Fwd P/E: 33.2×
Dividend yield: —
F-score: 8/9
Altman Z: 12.06
Beneish M: −2.17
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	20.80%	23.54%	24.20%	22.54%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	3	6	8	8
ROA Full definition →	13.81%	17.12%	17.58%	16.41%
ROIC Full definition →	14.86%	24.09%	24.15%	21.63%
Return on Tangible Assets Full definition →	47.35%	42.89%	45.87%	44.62%
Average Days of Receivables Full definition →	65.13	61.89	59.63	62.43
Free Cash Flow per Share Full definition →	12.63	14.96	14.60	12.49
Free Cash Flow Full definition →	3,202.30	3,796.10	3,710.30	3,193.80
Capital Expenditures Full definition →	(492.30)	(496.80)	(530.30)	(437.60)
Other line items
Cash ROIC Full definition →	10.43%	13.51%	13.94%	12.64%
Accounts Receivable Turnover Full definition →	6.08	6.25	6.43	6.55
Accounts Payable Turnover Full definition →	4.20	4.04	3.60	3.78
Inventory Turnover Full definition →	0.97	1.08	1.08	1.14
Average Days of Payables Full definition →	92.04	88.93	106.24	102.05
Days of Inventory on Hand Full definition →	437.30	365.48	383.59	372.85
Tax Rate Full definition →	(0.16)	(0.16)	(0.16)	(0.15)
Research and Development Expense of Revenue Full definition →	32.81%	31.04%	31.85%	32.58%
Selling, General and Administrative Expense of Revenue Full definition →	18.58%	15.95%	15.14%	14.61%
Share Based Compensation of Revenue Full definition →	5.16%	5.47%	5.62%	5.72%
Interest Coverage Full definition →	81.20	—	—	208.67
Operating CF/Net income Full definition →	0.93	0.97	0.98	0.92
Depreciation/Fixed assets Full definition →	0.14	0.13	0.14	0.14
Capex/Depreciation Full definition →	(2.07)	(2.24)	(2.44)	(2.09)
Revenue per Share Full definition →	51.09	49.61	48.08	46.94
Operating CF per Share Full definition →	14.57	16.92	16.69	14.20
Capex per Share Full definition →	(1.94)	(1.96)	(2.09)	(1.71)
Capex to Sales Full definition →	0.04	0.04	0.04	0.04

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly